Feb. 10 at 12:59 AM
$SLS Be Holding. What Happened at
$ABVX is about to Happen Here . . .
$5 to
$10 - double while expecting the P3, and then a T1 Trading Halt on the news and a +600% GAP UP to
$60 - and it Kept Climbing to a High of
$148. .. . https://www.reddit.com/r/sellasLifescience/comments/1qexr9p/sls_will_file_a_bla_for_aml_cr1_patients_at_the/?utm_source=share&utm_medium=web3x&utm_name=web3xcss&utm_term=1&utm_content=share_button
The Fact is the Instant the Phase 3 Results are Announced the SLS Share Price will Launch.
- The FDA already signed off on SAP, Gps gets Approval with a HR of .636 or Better - the whole market will Know Instantly
- Gps is Getting Fda Approval to treat upwards of 100,000 AML Patients Currently in Remission and 30K-40k / Year.
$280K Rev Per Patient Year 1, compounds
$110K Y2 + + +
- Gps will set records for Patient Uptake
2X 3X 4X + Survival Advantage - Near 100% Quality of Life
Ease of administration, FDA Already approved High Margin Type C Manufacture.
Ip Rights into 2037, FDA / Eu Fast Track and Orphan Designation + Rare Pediatric Review.
